Fig. 2
From: Non-invasive determination of disease activity in Crohn’s disease by serum luminex profiling
Correlation between disease activity indices and CXCL9. Using the cohort of CD patients for which all metrics of disease activity were available (n = 94), we assessed (a) CDAI vs. SES, (b) Histologic severity vs. CDAI, (c) Histologic severity vs. SES, (d) CDAI vs. CXCL9, (e) SES vs. CXCL9, and (f) Histologic severity vs. CXCL9 using Spearman’s correlation. NL = normal, Qui = quiescent, Mod = moderate, and Sev = severe. r = rho.
